C-MER MEDICAL (03309) spent HK$381,900 on October 20 to repurchase 200,000 shares.
Xima Medical (03309) announced that on October 20, 2025, the company invested HK$381,900...
C-MER MEDICAL (03309) announced that on October 20, 2025, the company repurchased 200,000 shares at a cost of HK$381,900, with a repurchase price of HK$1.90-1.91 per share.
Related Articles
YUEXIU PROPERTY (00123) successfully won the land in Jing'an District, Shanghai through a consortium for 7.737 billion yuan.
Beijing LabTech Instruments (688056.SH) intends to transfer 6.15% of the company's shares to Qingdao Innovation Investment.
APT ELECTRONICS (02551) plans to invest 20 million yuan in setting up a private equity investment fund.
YUEXIU PROPERTY (00123) successfully won the land in Jing'an District, Shanghai through a consortium for 7.737 billion yuan.
Beijing LabTech Instruments (688056.SH) intends to transfer 6.15% of the company's shares to Qingdao Innovation Investment.
APT ELECTRONICS (02551) plans to invest 20 million yuan in setting up a private equity investment fund.
RECOMMEND
Why European Automakers Are Opposing Dutch Sanctions
20/10/2025
Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025
Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025
